Started in October 2009 as a spin- off of Istituto di Ricerche di Biologia Molecolare P. Angeletti S.p.a., the Italian research site of Merck Research Laboratories. It is located in the Pontina farmlands lying south west of Rome, close to the sea coast. IRBM’s 20.000 square meters of buildings include laborator ies, administrative blocks, conference facilities and plant engineering shops. IRBM Science Park provides a broad spectrum of research services for Drug Discovery, Organic Chemistry, Biomedical Sciences and Biotechnology Applications, backed by decades of industry experience. IRBM Science Park provides world class services in drug and vaccine research. The Institute has expertise with small molecules, peptides, and biologics. IRBM Science Park ’s expert multidisciplinary team will assist you to discover small molecule and peptide therapeutics, star ting from lead identification, through lead optimization and up to the generation of a preclinical drug candidate. A state of the art GMP (Good Manufacturing Practices) production facility provides research grade and clinical grade recombinant adenoviral vectors for gene therapy and vaccine applications. IRBM S cience Park also offers independent access to individual research services.

A history of succes

From 2000 to 2009, >25 Preclinical candidates, including a marketed drug, were discovered at IRBM. Several new drugs progressed through preclinical and clinical development and achieved proof of concept in the clinic. The contributions of IRBM Scientists to these achievements are recognised in 800 papers and 100 patents.

---

IRBM Science Park srl - Sede Sociale: Via Pontina km 30,600 00040 Pomezia (RM)
C.F. e N° di iscrizione 10482601001 del Registro delle Imprese di Roma
Capitale Sociale: 1.000.000€ interamente versato